Cilostazol and Aspirin in Stroke and TIA
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 378 participants.
Also called NCT06522113
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 378 participants
- Sponsor
- Registry
-
NCT06522113
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06522113. Randomized; no masking; primary purpose treatment. Start 2019-07-18 (actual); primary completion 2022-10-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cilostazol and Aspirin in Stroke and TIA
- Condition
- Ischemic Stroke
- Condition
- TIA (transient ischemic attack)
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Incheon St.Mary's Hospital
Record details
- Record id
cardio:ct-nct06522113- Content hash
b32a6cef74177365ae85df06a41201fe5f2a3898c7978a5361b27156f385519b